LFSC
NASDAQ
$45.84
F/M EMERALD LIFE SCIENCES INNOVATION ETF (LFSC)
Sector:
Healthcare
Net assets
$122M
Inception date
October 30, 2024
Expense ratio
0.54%
Sharpe Ratio
2.25
Price Chart
Valuation
Net assets$122M
Forward P/E5.00
P/S8.76
P/B7.36
Profitability
Profit Margin-15.9%
Operating Margin-2195.3%
Financial Health
Debt-to-Equity-100.8%
Growth & Risk
EPS 5Y CAGR-9.12%
Revenue 5Y CAGR+27.22%
FCF 5Y CAGR+25.34%
Beta (5Y)1.03
Sharpe Ratio2.25